|
etoposide, VP-16
etoposide, VP-16
information and resources from the National Cancer Institute
VePesid
In combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer.
Bristol-Myers Squibb Dec 30 1986
Vepesid
In combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer.
Bristol-Myers Squibb Dec 30 1986
Vepesid
Refractory testicular tumors-in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical, chemotherapeutic and radiotherapeutic therapy.
Bristol-Myers Squibb Nov 10 1983
|
|
|
|
|
|
etoposide, VP-16
-->
|
